Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 44.7191 | 26 |
GSM780708 | Untreated after 4 days (C2_1) | 43.6362 | 20 |
GSM780709 | Untreated after 4 days (C3_1) | 45.0723 | 27 |
GSM780719 | Untreated after 4 days (C1_2) | 47.5662 | 39 |
GSM780720 | Untreated after 4 days (C2_2) | 47.3059 | 38 |
GSM780721 | Untreated after 4 days (C3_2) | 47.7352 | 40 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.8069 | 36 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.7731 | 56 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 47.8747 | 41 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.2124 | 52 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.931 | 32 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 50.3461 | 50 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 41.6797 | 12 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 44.3936 | 24 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 41.4262 | 11 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.6693 | 35 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 51.7204 | 53 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 45.1793 | 28 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.7633 | 48 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 51.6659 | 53 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.7076 | 48 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.0016 | 32 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 52.317 | 55 |